###begin article-title 0
###xml 89 93 89 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
Recent Insights in Islet Amyloid Polypeptide-Induced Membrane Disruption and Its Role in beta-Cell Death in Type 2 Diabetes Mellitus
###end article-title 0
###begin p 1
Recommended by Per Westermark
###end p 1
###begin p 2
This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 2
###begin p 3
###xml 200 204 200 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 277 281 274 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 380 384 374 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 864 868 855 856 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 56 61 <span type="species:ncbi:9606">human</span>
The presence of fibrillar protein deposits (amyloid) of human islet amyloid polypeptide (hIAPP) in the pancreatic islets of Langerhans is thought to be related to death of the insulin-producing islet beta-cells in type 2 diabetes mellitus (DM2). The mechanism of hIAPP-induced beta-cell death is not understood. However, there is growing evidence that hIAPP-induced disruption of beta-cell membranes is the cause of hIAPP cytotoxicity. Amyloid cytotoxicity by membrane damage has not only been suggested for hIAPP, but also for peptides and proteins related to other misfolding diseases, like Alzheimer's disease, Parkinson's disease, and prion diseases. Here we review the interaction of hIAPP with membranes, and discuss recent progress in the field, with a focus on hIAPP structure and on the proposed mechanisms of hIAPP-induced membrane damage in relation to beta-cell death in DM2.
###end p 3
###begin title 4
1. INTRODUCTION
###end title 4
###begin p 5
###xml 208 212 208 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 229 230 226 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 329 333 326 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 404 405 398 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 554 555 548 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 557 558 551 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 609 613 603 604 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 721 722 712 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 723 724 714 715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 883 887 874 875 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
Long before discovery of the primary structure of the main component of amyloid in the islets of Langerhans, detailed ultra structural investigations had revealed that islet amyloid was often in contact with beta-cell membranes [1]. In fact, it was found that amyloid fibrils were oriented perpendicular to the membrane of islet beta-cells, with some fibril bundles sticking into membrane invaginations [1]. In 1987, the main component of islet amyloid was identified as a 37-amino acid residue peptide called islet amyloid polypeptide (IAPP) or amylin [2, 3]. Since then, the presence of IAPP amyloid at the beta-cell membrane, and the concomitant morphological changes of these membranes, has been reported frequently [4-9]. These reports have contributed to the current hypothesis that the interaction between IAPP and cellular membranes could be a cause of IAPP cytotoxicity and beta-cell death in DM2. Before reviewing IAPP-membrane interactions, we will briefly discuss the present knowledge on IAPP fibril formation.
###end p 5
###begin title 6
2. IAPP FIBRIL FORMATION
###end title 6
###begin title 7
2.1. From monomer to fibril
###end title 7
###begin p 8
###xml 75 77 75 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 176 184 176 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1</xref>
###xml 445 447 445 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 129 134 <span type="species:ncbi:9606">human</span>
###xml 152 157 <span type="species:ncbi:10090">mouse</span>
###xml 319 323 <span type="species:ncbi:10090">mice</span>
###xml 350 355 <span type="species:ncbi:10090">mouse</span>
###xml 376 381 <span type="species:ncbi:9606">human</span>
The amino acid sequence of IAPP varies slightly from organism to organism [10]. For instance, six residues are different between human IAPP (hIAPP) and mouse IAPP (mIAPP) (see Figure 1). Importantly, the latter does not aggregate into amyloid fibrils, and amyloid is generally not observed in the pancreas of wild-type mice. Nevertheless, transgenic mouse models that express human IAPP develop fibrillar deposits and exhibit signs of diabetes [11].
###end p 8
###begin p 9
###xml 104 106 104 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 107 109 107 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 539 541 539 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 772 774 772 774 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 776 778 776 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 1183 1185 1183 1185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 1351 1359 1351 1359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2</xref>
###xml 1362 1364 1362 1364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
The in vitro aggregation and fibril formation of hIAPP have been studied extensively in the last years [12-22]. In most of these studies, hIAPP aggregation is initiated by dilution of, usually synthetic, monomeric hIAPP into a physiological buffer. This results in the "spontaneous" aggregation of hIAPP monomers into amyloid fibrils, as can be observed, for example, by electron microscopy. The in vitro aggregation of hIAPP is typically completed in a few hours, depending amongst others on peptide concentration and presence of lipids [18]. This is significantly faster than the aggregation of most other amyloidogenic peptides. Fibril formation of IAPP, as well as of some other amyloidogenic peptides, generally occurs via a nucleation dependent aggregation process [18, 23]. This means that the formation of a nucleus, usually a slow step, is required for initiation of the growth of stable fibrils. The nucleus is an ordered oligomeric hIAPP species that can serve as a template for fibrillar hIAPP. The kinetics of hIAPP fibril growth can be monitored in time by the commonly used method of specific binding of the fluorescent molecule Thioflavin T (ThT) to amyloid fibrils [24]. A kinetic trace of hIAPP fibril growth shows a lag phase and a sigmoidal transition that are typical for fibril growth of amyloidogenic proteins and peptides (see Figure 2) [23]. After dilution of initially monomeric hIAPP in buffer, the thermodynamically unfavourable process of nucleation occurs, although the initial horizontal baseline of the ThT curve indicates that no fibrils are formed in the beginning (lag phase). The sigmoidal increase in the ThT curve indicates propagation of fibril growth with consumption of monomer. Next to the monomeric and fibrillar states of hIAPP, several intermediate (oligomeric) states have been observed, as will be discussed later. Elongation of fibrils proceeds via addition of monomers or oligomers to both fibril ends.
###end p 9
###begin title 10
2.2. Three-dimensional molecular structure of hIAPP
###end title 10
###begin p 11
###xml 400 402 400 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 487 492 487 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 505 509 501 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 616 618 609 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 619 621 612 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 753 758 746 747 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 781 783 770 772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 863 868 852 853 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 913 917 898 899 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 1012 1017 994 995 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
The three-dimensional structure of amyloid fibrils, and lately also the structure of monomers and oligomers, has been the subject of research into the molecular background of amyloid diseases. However, only little structural information is available for the IAPP monomer, oligomer, and fibril. In 1992, the first, limited information of the three-dimensional structure of soluble hIAPP was obtained [25]. It was shown that hIAPP exhibits a random coil structure with small components of alpha-helical and beta-sheet conformations. Recent studies confirmed that soluble hIAPP has mainly unordered backbone structure [26-28]. In contrast, hIAPP dissolved in the organic solvent trifluoroethanol (TFE, a membrane mimicking solvent) predominantly adopts an alpha-helical conformation [25]. Our observations have indicated that hIAPP dissolved in TFE initially adopts alpha-helical structure, before transforming into beta-sheet structure (unpublished results). These observations suggest that hIAPP could also adopt alpha-helical structure in a membrane environment.
###end p 11
###begin p 12
###xml 118 119 118 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 121 123 121 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 124 126 124 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 297 302 297 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 322 324 318 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 453 458 449 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 498 502 490 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 624 629 613 614 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 645 649 630 631 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 651 653 633 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 655 657 637 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 837 839 819 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 1009 1013 991 992 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 993 998 <span type="species:ncbi:9606">human</span>
hIAPP oligomers or aggregates ranging from dimers up to 6000 molecules have been reported by several research groups [7, 29-31]. These oligomers appear to represent intermediates on the path to fibril formation. There are recent indications that hIAPP oligomers, in presence of membranes, exhibit alpha-helical structure [28]. This is surprising since it would seem thermodynamically unfavourable for a monomer with random coil structure to first adopt alpha-helical structure before changing into beta-sheet rich fibrillar structure. Aggregation intermediates have been observed for many types of amyloid proteins, such as alpha-synuclein and Abeta [32, 33]. Glabe and coworkers have produced a conformation-dependent antibody that is specific for soluble oligomers and does not recognize natively folded proteins, monomer, or fibrils [34]. They showed that this antibody recognizes soluble oligomers from a wide variety of amyloid-forming peptides and proteins such as hIAPP, Prion 106-126, human insulin, Abeta peptide, and polyglutamine, which suggests that these oligomers might have a common structure.
###end p 12
###begin p 13
###xml 209 211 209 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 213 215 213 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">35</xref>
###xml 216 218 216 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
###xml 320 324 320 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 462 466 459 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 477 482 471 472 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 502 504 492 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 560 562 550 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 600 604 590 591 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
The three-dimensional structure of hIAPP fibrils has been studied by various high-resolution techniques, like electron microscopy, X-ray diffraction, electron diffraction, and electron paramagnetic resonance [26, 35-38]. These studies clearly reveal that hIAPP fibrils contain a significant amount of well-ordered cross-beta structure, typical of amyloid fibrils. During fibril formation, hIAPP undergoes a conformational change from random coil to a mixture of beta-sheet and alpha-helical structure [26]. These results are consistent with the work of Kayed [15], who also measured a random coil to beta-sheet transition for hIAPP fibril formation. hIAPP fibrils are polymorphic, ranging from thin protofilaments with a diameter of about 5 nm to thicker fibrils with diameter of up to 15 nm that appear to be rope-like bundles of protofilaments. The predominant type of fibril contains three protofilaments in a left-handed coil with a pitch of 25-50 nm.
###end p 13
###begin title 14
2.3. Which amino acid residues are important for hIAPP fibril formation?
###end title 14
###begin p 15
###xml 105 107 105 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 308 310 308 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">39</xref>
###xml 483 487 483 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
Structural studies have shown that amino acid residues 20-29 of hIAPP are crucial for amyloid formation [12]. A proline scan of this decamer (hIAPP20-29) has demonstrated that substitution of a single proline at either position 22, 24 or at positions 26-28 leads to a drastic reduction of amyloid formation [39]. Note that three of the six differences between hIAPP and the nonamyloidogenic mIAPP involve a proline, a residue that is predicted to disrupt ordered structure, like the beta-sheet structure in amyloid fibrils.
###end p 15
###begin p 16
###xml 90 94 90 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 370 372 367 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B40">40</xref>
###xml 373 375 370 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B42">42</xref>
###xml 545 547 542 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">43</xref>
Currently, research groups are developing molecules in an attempt to reduce hIAPP-induced beta-cell death by inhibiting hIAPP fibril formation. Some of these "inhibitors" are based on synthetically modified hIAPP peptides or hIAPP fragments that are not able to form fibrils themselves, but are suggested to bind to, and to stop the elongation of growing hIAPP fibrils [40-42]. A recent study indicated that a single amino acid substitution in hIAPP, where Ile on position 26 is replaced by Pro (I26P), yields a potent fibrillization inhibitor [43].
###end p 16
###begin p 17
###xml 226 228 226 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B44">44</xref>
###xml 308 316 308 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1</xref>
###xml 442 444 442 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B45">45</xref>
###xml 864 866 864 866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B46">46</xref>
###xml 868 870 868 870 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B47">47</xref>
###xml 973 975 973 975 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
###xml 231 236 <span type="species:ncbi:9606">Human</span>
Although residues 20-29 play an important role in hIAPP fibril formation, these may not be the only residues involved. It has been hypothesized that aromatic-aromatic interactions are also important in hIAPP fibril formation [44]. Human IAPP contains three aromatic residues at positions 15, 23, and 37 (see Figure 1). The aromatic-aromatic and aromatic-hydrophobic interactions in amyloid formation were studied using a hIAPP triple mutant [45]. The triple mutant F15L/F23L/Y37L, lacking aromatic residues, still forms amyloid fibrils in vitro, indicating that the aromatic residues are not essential in hIAPP fibril formation. However, the substitution decreases the rate of fibril formation and alters the tendency of fibrils to aggregate. Some studies demonstrate that the amino acid region from residues 11 to 20 is also important for hIAPP fibril formation [46, 47]. A recent study shows that the hIAPP fragment consisting of residues 14-20 can form amyloid fibrils [38].
###end p 17
###begin p 18
###xml 54 62 54 62 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1</xref>
###xml 344 346 344 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B48">48</xref>
###xml 413 417 413 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 578 580 575 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B49">49</xref>
hIAPP contains a single histidine at position 18 (see Figure 1), which is the only residue in this peptide that has a charge that depends on pH in a physiological pH range. Consequently, fibril formation of hIAPP could depend on the pH. A recent study showed that hIAPP fibril formation is faster at a lower pH (4.0) than at a higher pH (8.8) [48]. This could be important in a physiological context since in the beta-cell granules of the pancreas, where hIAPP is stored, the pH is 5.5, but when hIAPP is released into the extracellular compartment, it experiences a pH of 7.4 [49].
###end p 18
###begin p 19
###xml 109 117 109 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1</xref>
###xml 330 332 330 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
Another characteristic of hIAPP is the intramolecular disulfide bond between cysteines residues 2 and 7 (see Figure 1). The disulfide does not contribute to the amyloid fiber core structure; however it somehow must play a central role in the assembly mechanism, since loss of the disulfide significantly reduces fibril formation [20].
###end p 19
###begin title 20
3. hIAPP AGGREGATION AND FIBRIL FORMATION IN THE PRESENCE OF MEMBRANES
###end title 20
###begin title 21
3.1. Membrane phospholipids catalyse hIAPP fibril formation
###end title 21
###begin p 22
###xml 83 85 83 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 87 89 87 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B50">50</xref>
###xml 91 93 91 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B51">51</xref>
###xml 260 262 260 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B50">50</xref>
###xml 573 575 573 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sn</italic>
###xml 673 675 673 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 677 679 677 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B50">50</xref>
###xml 681 683 681 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B51">51</xref>
###xml 827 829 827 829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 831 833 831 833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B50">50</xref>
It has been observed that phospholipid membranes promote the aggregation of hIAPP [28, 50, 51]. In the presence of phospholipids, the kinetic profile of hIAPP fibril growth is characterized by a reduction in the lag time resulting in earlier fibril formation [50]. Cellular membranes could accelerate hIAPP fibril formation by enhancing nucleation. The lipid composition may play an important role in this process, since it has been demonstrated that hIAPP aggregation is accelerated in the presence of membranes that contain negatively charged lipids such as 1,2-dioleoyl-sn-glycero-3-phospho-L-serine (DOPS) or 1,2-Dioleoyl-sn-Glycero-3-[Phospho-rac-(1-glycerol)](DOPG) [27, 50, 51]. In the presence of such membranes, hIAPP fibril formation occurs within a few minutes as opposed to a few hours in the absence of membranes [27, 50]. A membrane-induced change in the conformation in hIAPP could possibly result in formation and/or stabilization of a nucleus, which could in turn result in acceleration of hIAPP fibril formation. Hence, elucidation of the conformation of hIAPP in interaction with the membrane is an important issue. Knowledge of this conformation would give valuable insights into the mechanism of membrane damage and would aid in developing new drugs and/or finding new targets for the treatment of DM2.
###end p 22
###begin title 23
3.2. Insight in the conformation of membrane-interacting hIAPP
###end title 23
###begin p 24
###xml 158 160 158 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 162 164 162 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 166 168 166 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B52">52</xref>
###xml 282 284 282 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sn</italic>
###xml 384 386 384 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sn</italic>
###xml 472 477 472 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 497 499 493 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 583 585 579 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 687 691 683 684 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 748 750 741 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 848 850 841 843 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B53">53</xref>
Recently, studies have been performed to determine the conformation of hIAPP that interacts with model membranes, that is, large unilamellar vesicles (LUVs) [27, 28, 52]. In these studies, the LUVs are composed of a combination of a neutral phospholipid, for instance, 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC), and a negatively charged phospholipid, for instance, 1,2-dioleoyl-sn-glycero-3-phospho-L-serine (DOPS). In the presence of LUVs, hIAPP initially displays alpha-helical structure [27], corresponding with the structure of hIAPP in the membrane-mimicking solvent TFE [25]. However, after 40 minutes incubation with LUVs, the conformation of hIAPP changes to predominantly beta-sheet conformation, characteristic of fibril formation [27]. Recently, the structure of hIAPP in membrane bilayers was studied using microscopy techniques [53]. It was found that hIAPP forms pores that are composed of five subunits, in which each subunit is suggested to represent an hIAPP monomer. This hIAPP morphology was connected to channel-like behavior in planar bilayers, indicating that these oligomeric hIAPP pores could incorporate in membranes and change their barrier properties. Unfortunately, high-resolution structural information of hIAPP in a membrane environment is still lacking, mainly because of the instability of the membrane-interacting hIAPP aggregates. Preliminary results of our group indicate that hIAPP fibrils grown in the presence of phospholipids have the same characteristic structure as fibrils formed in the absence of lipids.
###end p 24
###begin title 25
3.3. Which residues are important in the interaction with membrane?
###end title 25
###begin p 26
###xml 396 404 396 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1</xref>
###xml 663 665 663 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B50">50</xref>
###xml 892 894 892 894 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B54">54</xref>
It is likely that the presence of membranes causes additional residues in IAPP to be involved in fibril formation, as compared to the situation without membranes. Several residues that are important for hIAPP-membrane interactions can be identified. It can be anticipated that the positively charged residues, which are all located at the N-terminal part of hIAPP at positions 1, 11, and 18 (see Figure 1), will be important in the interaction of hIAPP with negatively charged phospholipid membranes. Indeed, there are indications that hIAPP molecules cluster at the membrane surface, prior to fibrillogenesis, with their N-termini oriented towards the membrane [50]. More recently, it was shown that an N-terminal hIAPP fragment (hIAPP1-19) has a significantly higher ability to insert in phospholipid monolayers than a fragment from the central, amyloidogenic region of hIAPP (hIAPP20-29) [54]. These findings suggest that the N-terminal part of hIAPP, whilst not significantly involved in hIAPP fibril growth, is important in light of hIAPP-membrane interactions.
###end p 26
###begin title 27
4. MECHANISM OF CYTOTOXICITY
###end title 27
###begin p 28
###xml 230 232 230 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B55">55</xref>
###xml 234 236 234 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B56">56</xref>
###xml 407 408 407 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 410 411 410 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 412 413 412 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 557 561 557 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 739 741 736 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B57">57</xref>
###xml 1090 1092 1087 1089 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B58">58</xref>
###xml 1094 1096 1091 1093 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B59">59</xref>
###xml 1259 1260 1256 1257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 1262 1264 1259 1261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 1266 1268 1263 1265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 1270 1272 1267 1269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 1274 1276 1271 1273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B50">50</xref>
###xml 1278 1280 1275 1277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B51">51</xref>
###xml 1282 1284 1279 1281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B54">54</xref>
###xml 1286 1288 1283 1285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B57">57</xref>
###xml 1290 1292 1287 1289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B60">60</xref>
###xml 1293 1295 1290 1292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B63">63</xref>
###xml 1606 1607 1603 1604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 1609 1611 1606 1608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 1613 1615 1610 1612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 1617 1619 1614 1616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 1621 1623 1618 1620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B57">57</xref>
###xml 1625 1627 1622 1624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B59">59</xref>
###xml 1629 1631 1626 1628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B60">60</xref>
###xml 1633 1635 1630 1632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B64">64</xref>
###xml 905 910 <span type="species:ncbi:10090">mouse</span>
In 1993, work on the amyloidogenic Alzheimer's related peptide Abeta had indicated that an amyloidogenic protein can form ion-selective membrane channels, providing a first hypothesis for the mechanism of amyloid (neuro)toxicity [55, 56]. The observations that IAPP fibrils are located at the cellular membrane in the Islets of Langerhans and that this is accompanied by alterations in membrane morphology [1, 4-9] made researchers hypothesize that the membrane might be the target of cytotoxic IAPP and that this could cause death of the insulin producing beta-cells, similar to Abeta neurotoxicity in Alzheimer's disease. The first experimental evidence that indeed hIAPP can cause membrane disruption came from work by the Kagan group [57]. It was found from experiments with planar lipid bilayers that synthetic hIAPP forms ion-permeable channels "pores" in the membrane, whereas the nonamyloidogenic mouse IAPP does not form channels. Mature hIAPP fibrils were found to be less cytotoxic; moreover, they did not cause significant membrane disruption in comparison to oligomeric hIAPP [58, 59]. Still, the exact mechanism of hIAPP-induced membrane disruption is far from understood, and various mechanisms have been hypothesized during the last 10 years [7, 29, 31, 34, 50, 51, 54, 57, 60-63]. It is, for example, unclear what the exact nature of the hIAPP species that interacts with or even disrupts membranes is. The main hypothesis, based on in vitro evidence, suggests a major role for a specific prefibrillar hIAPP aggregate, commonly known as hIAPP oligomer, as the membrane-disrupting species [7, 29, 31, 34, 57, 59, 60, 64]. The various suggested mechanisms for hIAPP-induced membrane disruption will be discussed below.
###end p 28
###begin title 29
4.1. hIAPP oligomers cause membrane damage and are cytotoxic
###end title 29
###begin p 30
###xml 198 200 198 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B65">65</xref>
###xml 318 322 318 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 375 376 372 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 378 380 375 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 382 384 379 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 386 388 383 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 390 392 387 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B53">53</xref>
###xml 394 396 391 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B57">57</xref>
###xml 398 400 395 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B60">60</xref>
###xml 402 404 399 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B64">64</xref>
###xml 469 471 466 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B53">53</xref>
###xml 473 475 470 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B57">57</xref>
###xml 534 536 531 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B55">55</xref>
###xml 538 540 535 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B66">66</xref>
###xml 636 638 633 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 795 797 792 794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 799 801 796 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B51">51</xref>
###xml 803 805 800 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B59">59</xref>
###xml 807 809 804 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B63">63</xref>
###xml 811 813 808 810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B67">67</xref>
Recently, it has been suggested that prefibrillar aggregates (or oligomers), formed early during aggregation and not mature amyloid fibrils are the cytotoxic species in protein misfolding diseases [65]. Considering amyloid cytotoxicity in DM2, the prevailing view is that IAPP-induced membrane damage, and concomitant beta-cell death, is caused by cytotoxic hIAPP oligomers [7, 28, 29, 31, 53, 57, 60, 64]. There are indications that these oligomers form ion channels [53, 57], as has been suggested for other amyloidogenic proteins [55, 66]. Other studies indicate that hIAPP oligomer-induced membrane damage is not specific for ions [31] but results in membrane leakage of molecules with a size of up to 600 Da (Calcein), indicating a general membrane disruption mechanism by hIAPP oligomers [28, 51, 59, 63, 67].
###end p 30
###begin p 31
###xml 141 142 141 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 375 377 375 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 379 381 379 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B60">60</xref>
###xml 535 537 535 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 539 541 539 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B60">60</xref>
###xml 776 778 776 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B59">59</xref>
###xml 1196 1198 1196 1198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B64">64</xref>
###xml 1336 1340 1336 1337 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 1357 1359 1354 1356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B68">68</xref>
###xml 1449 1453 1446 1447 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 1522 1524 1516 1518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B69">69</xref>
###xml 1622 1626 1616 1617 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 666 671 <span type="species:ncbi:9606">human</span>
###xml 1469 1484 <span type="species:ncbi:10090">transgenic mice</span>
Small hIAPP aggregates have been shown to be cytotoxic in cell cultures, and these aggregates were also able to destabilize model membranes [7]. Similarly, oligomeric hIAPP was found to form membrane pores, allowing molecules with the size of a calcium ion to pass. These pores disappeared, and membrane damage decreased, when hIAPP fibrils grew and oligomers were consumed [29, 60]. Electron microscopy analysis showed that hIAPP formed spherical shapes with a diameter of 3 to 20 nm, consistent with the presence of hIAPP oligomers [31, 60]. In a test tube, oligomeric hIAPP can be prepared under specific experimental conditions. Addition of such preparations to human neuroblastoma cells that were loaded with fluorescent dye resulted in the cellular leakage of this dye [59]. This indicates that hIAPP oligomers, when applied to the outside of cells, are cytotoxic via a general membrane destabilizing effect and not via a specific ion pore. The monomeric and fibrillar form of hIAPP clearly did not have this effect. Later it was also shown that when applied from the inside of cells, using cells that overexpress hIAPP, the hIAPP oligomers are also able to perform their cytotoxic action [64]. Recently, it has been suggested that ER and mitochondrial membranes might be the target of cytotoxic hIAPP, resulting in ER stress and beta-cell apoptosis [68]. Moreover, intracellular hIAPP oligomers were indirectly demonstrated in the pancreatic beta-cells of hIAPP-transgenic mice using an oligomer-specific antibody [69]. The latter study also showed that oligomer-specific antibodies could not prevent hIAPP-induced beta-cell death, indicating that toxic events might occur inside the cell.
###end p 31
###begin p 32
###xml 146 148 146 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 150 152 150 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B60">60</xref>
###xml 302 304 302 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 398 406 398 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3</xref>
The exact mechanism of membrane disruption by hIAPP oligomers is not known. Some groups show that preassembled hIAPP oligomers disrupt membranes [31, 60], whereas others suggest that hIAPP monomers first interact with the membrane and only then form oligomeric hIAPP with membrane disrupting capacity [28]. These two models of membrane damage by hIAPP oligomers have been schematically depicted in Figure 3.
###end p 32
###begin p 33
In conclusion, many observations indicate that hIAPP oligomers are a likely candidate for inducing cell death. In contrast, hIAPP fibrils are found not to damage membranes and could in fact be the result of a physiological mechanism in which toxic oligomer species are disposed of in a nontoxic, fibrillar form.
###end p 33
###begin title 34
4.2. Membrane damage by fibril growth at the membrane
###end title 34
###begin p 35
###xml 596 604 596 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3</xref>
###xml 746 748 746 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B52">52</xref>
###xml 750 752 750 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B54">54</xref>
###xml 926 934 926 934 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3</xref>
###xml 1300 1301 1300 1301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 1303 1304 1303 1304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 1306 1307 1306 1307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 1333 1334 1333 1334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 1336 1337 1336 1337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 1339 1341 1339 1341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B70">70</xref>
###xml 1500 1508 1500 1508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2</xref>
###xml 1689 1691 1689 1691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B71">71</xref>
###xml 1885 1887 1885 1887 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B72">72</xref>
###xml 2230 2232 2230 2232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B51">51</xref>
###xml 2234 2236 2234 2236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B73">73</xref>
###xml 2238 2240 2238 2240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B74">74</xref>
###xml 2255 2257 2255 2257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B75">75</xref>
In addition to the hypothesis that oligomers are the toxic species, recent reports suggest also other mechanisms for hIAPP cytotoxicity. One such hypothesis is that membrane damage is not caused by a specific hIAPP species, such as an oligomer, but by the process of fibril growth at the cellular membrane. There are several recent indications that growth of hIAPP fibrils at the membrane can cause membrane damage. In this model, the initial steps of the interaction of hIAPP with membranes are adsorption, followed by insertion of hIAPP into the membrane, either as monomer or as oligomer (see Figure 3). The interaction of monomeric hIAPP with membranes is likely as monomeric hIAPP has a strong tendency to insert in phospholipid monolayers [52, 54]. In the next step, interactions of membrane-located hIAPP species with each other, or with hIAPP species in solution, lead to growth of fibrils at the membrane (model 3 in Figure 3). The mechanism of membrane damage could entail growth of a rigid hIAPP fibril on a flexible phospholipid bilayer, which would result in a forced change in membrane curvature. This change in membrane curvature leads to deformation of the shape of the membrane. Interestingly, disruption, blebbing and vesicle budding of cell membranes in the presence of synthetic [5, 7, 9] and cell-derived hIAPP [6, 8, 70] have been noticed in many studies. Our recent results indicate that the kinetics of membrane damage is very similar to the kinetics of fibril formation (see Figure 2). Both processes, fibril formation and membrane damage, were characterized by the presence of a lag phase and a strong enhancing effect on the kinetics upon the addition of seeds [71]. In case of the Alzheimer's disease-related Abeta peptide, it has been suggested recently that not a particular species but ongoing amyloid fibrillogenesis is responsible for membrane damage [72]. Together, these notions suggest that a cytotoxic mechanism based on fibril growth at the membrane could represent a common mechanism for amyloid-induced cell death. Finally, another factor that could contribute to membrane damage by fibril growth is uptake of membrane lipids in amyloid, a phenomenon that has been observed, both in vitro [51, 73, 74] and in vivo [75].
###end p 35
###begin title 36
5. INITIATION OF HARMFUL IAPP-MEMBRANE INTERACTIONS IN DM2
###end title 36
###begin p 37
###xml 95 99 95 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 445 447 442 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 634 636 631 633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B76">76</xref>
###xml 637 639 634 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B78">78</xref>
###xml 697 701 694 695 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 824 826 818 820 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B79">79</xref>
###xml 990 992 984 986 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 994 996 988 990 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B50">50</xref>
###xml 1046 1048 1040 1042 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 1050 1052 1044 1046 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B51">51</xref>
###xml 1420 1422 1414 1416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B80">80</xref>
###xml 1462 1464 1456 1458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 60 66 <span type="species:ncbi:9606">people</span>
###xml 435 443 <span type="species:ncbi:9606">patients</span>
###xml 794 799 <span type="species:ncbi:10090">mouse</span>
###xml 804 807 <span type="species:ncbi:10116">rat</span>
Since the combination of hIAPP and membranes in nondiabetic people does not normally result in beta-cell death; certain DM2-related conditions should exist that initiate hIAPP-induced membrane damage. An increase in the level of hIAPP, which is coproduced and cosecreted with insulin, in a state of insulin resistance, could initiate hIAPP fibril formation. More specific, an altered ratio of insulin to hIAPP, as observed in diabetic patients [16], could lead to a decrease of the inhibitory effect of insulin on hIAPP amyloid fibril formation. This inhibitory effect of insulin on hIAPP fibril formation has been observed in vitro [76-78]. On the other hand, a changing lipid composition of the beta-cells, in particular an increase in negatively charged lipids as inferred from studies with mouse and rat models for DM2 [79], could also trigger an increase in hIAPP-membrane interactions. In vitro studies show that negatively charged lipids increase the rate of hIAPP fibril formation [27, 50] and also enhance hIAPP-induced membrane damage [28, 51]. The membrane itself could promote hIAPP growth by increasing the local concentration of (membrane bound) hIAPP and/or by promoting a specific orientation or conformation of the peptide that makes hIAPP molecules more susceptible to aggregation into oligomers or fibrils. Recent research shows that not only phospholipid bilayers, but also a polyanion like heparin [80] or a dichloromethane/water interface [22] can induce nucleation and aggregation of hIAPP. These results indicate that charge and a hydrophobic/hydrophilic interface (both present in biological membranes) are important factors that promote hIAPP fibril formation.
###end p 37
###begin title 38
6. FUTURE PERSPECTIVES AND CHALLENGES
###end title 38
###begin p 39
###xml 273 277 273 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 830 834 827 828 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 1233 1237 1227 1228 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 579 591 <span type="species:ncbi:9606">participants</span>
During the last years, the understanding of hIAPP-membrane interactions has significantly increased. We have now important indications that oligomeric hIAPP, in contrast to fibrillar hIAPP, is the main species involved in membrane damage and is a likely candidate to cause beta-cell death in DM2. However, in a cellular environment, such toxic oligomers have not (yet) been directly demonstrated. More insight is required into the question whether hIAPP oligomers are inherently cytotoxic and persist as toxic oligomer after their cytotoxic action, or whether they are transient participants in the process of fibril growth at the membrane. A major challenge is to elucidate the mechanism by which hIAPP induces membrane damage and cytotoxicity. This knowledge would be essential to develop new strategies to battle hIAPP-induced beta-cell death in DM2. Determination of the three-dimensional structure of membrane disrupting hIAPP would be an important contribution in elucidation of the cytotoxic mechanism. Moreover, the importance of hIAPP-membrane interactions, discussed here, indicates that inhibition or alteration of hIAPP-membrane interactions might be an alternative strategy to reduce amyloid cytotoxicity and to prevent beta-cell death in DM2, in addition to the "traditional strategy" to reduce amyloid by the development of molecules that inhibit amyloid fibril formation.
###end p 39
###begin title 40
ACKNOWLEDGMENTS
###end title 40
###begin p 41
This research was financially supported by the Dutch Diabetes Research Foundation (Grant no. 2002.00.019). Lucie Khemtemourian was supported by the European Commission (Marie Curie Postdoctoral fellowship).
###end p 41
###begin article-title 42
Fine structure of islets of Langerhans in insular amyloidosis
###end article-title 42
###begin article-title 43
###xml 19 24 <span type="species:ncbi:9606">human</span>
###xml 77 80 <span type="species:ncbi:9685">cat</span>
Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells
###end article-title 43
###begin article-title 44
###xml 95 103 <span type="species:ncbi:9606">patients</span>
Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients
###end article-title 44
###begin article-title 45
Islet amyloid formed from diabetes-associated peptide may be pathogenic in type-2 diabetes
###end article-title 45
###begin article-title 46
Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus
###end article-title 46
###begin article-title 47
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human islet amyloid polypeptide expression in COS-1 cells. A model of intracellular amyloidogenesis
###end article-title 47
###begin article-title 48
The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles
###end article-title 48
###begin article-title 49
###xml 33 38 <span type="species:ncbi:9606">human</span>
Intracellular amyloidogenesis by human islet amyloid polypeptide induces apoptosis in COS-1 cells
###end article-title 49
###begin article-title 50
###xml 119 123 119 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 66 71 <span type="species:ncbi:9606">human</span>
Ultrastructural evidence that apoptosis is the mechanism by which human amylin evokes death in RINm5F pancreatic islet beta-cells
###end article-title 50
###begin article-title 51
Sequence divergence in a specific region of islet amyloid polypeptide (IAPP) explains differences in islet amyloid formation between species
###end article-title 51
###begin article-title 52
###xml 155 160 <span type="species:ncbi:10090">mouse</span>
Extensive islet amyloid formation is induced by development of type II diabetes mellitus and contributes to its progression: pathogenesis of diabetes in a mouse model
###end article-title 52
###begin article-title 53
Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation
###end article-title 53
###begin article-title 54
Effect of pH and insulin on fibrillogenesis of islet amyloid polypeptide in vitro
###end article-title 54
###begin article-title 55
Contribution of advanced glycosylation to the amyloidogenicity of islet amyloid polypeptide
###end article-title 55
###begin article-title 56
Conformational transitions of islet amyloid polypeptide (IAPP) in amyloid formation in vitro
###end article-title 56
###begin article-title 57
###xml 58 62 58 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 26 31 <span type="species:ncbi:9606">human</span>
Identification of a novel human islet amyloid polypeptide beta-sheet domain and factors influencing fibrillogenesis
###end article-title 57
###begin article-title 58
Islet amyloid polypeptide: identification of long-range contacts and local order on the fibrillogenesis pathway
###end article-title 58
###begin article-title 59
Islet amyloid: phase partitioning and secondary nucleation are central to the mechanism of fibrillogenesis
###end article-title 59
###begin article-title 60
Direct measurement of islet amyloid polypeptide fibrillogenesis by mass spectrometry
###end article-title 60
###begin article-title 61
Contribution of the intrinsic disulfide to the assembly mechanism of islet amyloid
###end article-title 61
###begin article-title 62
###xml 30 35 30 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
Direct detection of transient alpha-helical states in islet amyloid polypeptide
###end article-title 62
###begin article-title 63
Fiber-dependent amyloid formation as catalysis of an existing reaction pathway
###end article-title 63
###begin article-title 64
Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins
###end article-title 64
###begin article-title 65
Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavine T
###end article-title 65
###begin article-title 66
###xml 13 17 13 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
Promotion of beta-structure by interaction of diabetes associated polypeptide (amylin) with phosphatidylcholine
###end article-title 66
###begin article-title 67
Amyloid fibril formation from full-length and fragments of amylin
###end article-title 67
###begin article-title 68
Lipid membranes modulate the structure of islet amyloid polypeptide
###end article-title 68
###begin article-title 69
###xml 53 58 53 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
Conserved and cooperative assembly of membrane-bound alpha-helical states of islet amyloid polypeptide
###end article-title 69
###begin article-title 70
Protofibrillar islet amyloid polypeptide permeabilizes synthetic vesicles by a pore-like mechanism that may be relevant to type II diabetes
###end article-title 70
###begin article-title 71
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human amylin oligomer growth and fibril elongation define two distinct phases in amyloid formation
###end article-title 71
###begin article-title 72
Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases
###end article-title 72
###begin article-title 73
###xml 103 108 103 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 87 92 <span type="species:ncbi:9606">human</span>
###xml 97 102 <span type="species:ncbi:10090">mouse</span>
Inhibition of fibrillization and accumulation of prefibrillar oligomers in mixtures of human and mouse alpha-synuclein
###end article-title 73
###begin article-title 74
Common structure and toxic function of amyloid oligomers implies a common mechanism of pathogenesis
###end article-title 74
###begin article-title 75
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis
###end article-title 75
###begin article-title 76
###xml 34 39 <span type="species:ncbi:9606">human</span>
Polymorphic fibrillar assembly of human amylin
###end article-title 76
###begin article-title 77
Structural characterisation of islet amyloid polypeptide fibrils
###end article-title 77
###begin article-title 78
Identifying structural features of fibrillar islet amyloid polypeptide using site-directed spin labeling
###end article-title 78
###begin article-title 79
###xml 35 39 35 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
Atomic structures of amyloid cross-beta spines reveal varied steric zippers
###end article-title 79
###begin article-title 80
###xml 80 85 80 85 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">20&#8211;29</sub>
###xml 68 73 <span type="species:ncbi:9606">human</span>
Effects of sequential proline substitutions on amyloid formation by human amylin20-29
###end article-title 80
###begin article-title 81
###xml 85 90 85 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 42 47 <span type="species:ncbi:9606">human</span>
Inhibition of amyloid fibril formation of human amylin by N-alkylated amino acid and alpha-hydroxy acid residue containing peptides
###end article-title 81
###begin article-title 82
Inhibition of islet amyloid polypeptide fibril formation: a potential role for heteroaromatic interactions
###end article-title 82
###begin article-title 83
###xml 52 57 <span type="species:ncbi:9606">human</span>
Design of a mimic of nonamyloidogenic and bioactive human islet amyloid polypeptide (IAPP) as nanomolar affinity inhibitor of IAPP cytotoxic fibrillogenesis
###end article-title 83
###begin article-title 84
###xml 58 63 <span type="species:ncbi:9606">human</span>
A single-point mutation converts the highly amyloidogenic human islet amyloid polypeptide into a potent fibrillization inhibitor
###end article-title 84
###begin article-title 85
Analysis of the minimal amyloid-forming fragment of the islet amyloid polypeptide-an experimental support for the key role of the phenylalanine residue in amyloid formation
###end article-title 85
###begin article-title 86
Aromatic interactions are not required for amyloid fibril formation by islet amyloid polypeptide but do influence the rate of fibril formation and fibril morphology
###end article-title 86
###begin article-title 87
Identification and characterization of a novel molecular-recognition and self-assembly domain within the islet amyloid polypeptide
###end article-title 87
###begin article-title 88
###xml 68 73 <span type="species:ncbi:9606">human</span>
Identification of minimal peptide sequences in the (8-20) domain of human islet amyloid polypeptide involved in fibrillogenesis
###end article-title 88
###begin article-title 89
###xml 43 48 <span type="species:ncbi:9606">human</span>
The role of His-18 in amyloid formation by human islet amyloid polypeptide
###end article-title 89
###begin article-title 90
Islet amyloid: a complication of islet dysfunction or an aetiological factor in type 2 diabetes?
###end article-title 90
###begin article-title 91
Phospholipid catalysis of diabetic amyloid assembly
###end article-title 91
###begin article-title 92
Islet amyloid polypeptide-induced membrane leakage involves uptake of lipids by forming amyloid fibers
###end article-title 92
###begin article-title 93
Mechanism of islet amyloid polypeptide fibrillation at lipid interfaces studied by infrared reflection absorption spectroscopy
###end article-title 93
###begin article-title 94
Amyloid ion channels: a common structural link for protein-misfolding disease
###end article-title 94
###begin article-title 95
Islet amyloid polypeptide inserts into phospholipid monolayers as monomer
###end article-title 95
###begin article-title 96
###xml 69 73 69 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 84 88 81 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
Giant multilevel cation channels formed by Alzheimer disease amyloid beta-protein [AbetaP-(1-40)] in bilayer membranes
###end article-title 96
###begin article-title 97
###xml 23 27 23 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 38 42 35 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 62 64 56 58 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
The ability of amyloid beta-protein [AbetaP (1-40)] to form Ca2+ channels provides a mechanism for neuronal death in Alzheimer's disease
###end article-title 97
###begin article-title 98
Pore formation by the cytotoxic islet amyloid peptide amylin
###end article-title 98
###begin article-title 99
###xml 84 88 84 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 29 34 <span type="species:ncbi:9606">human</span>
The aggregation potential of human amylin determines its cytotoxicity towards islet beta-cells
###end article-title 99
###begin article-title 100
Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers
###end article-title 100
###begin article-title 101
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human islet amyloid polypeptide forms transient membrane-active prefibrillar assemblies
###end article-title 101
###begin article-title 102
Neutron diffraction reveals sequence-specific membrane insertion of pre-fibrillar islet amyloid polypeptide and inhibition by rifampicin
###end article-title 102
###begin article-title 103
###xml 47 52 <span type="species:ncbi:9606">human</span>
Inhibitors can arrest the membrane activity of human islet amyloid polypeptide independently of amyloid formation
###end article-title 103
###begin article-title 104
###xml 106 111 <span type="species:ncbi:9606">human</span>
Atomic force microscopy reveals defects within mica supported lipid bilayers induced by the amyloidogenic human amylin peptide
###end article-title 104
###begin article-title 105
###xml 59 63 59 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 14 19 <span type="species:ncbi:9606">human</span>
###xml 134 139 <span type="species:ncbi:9606">human</span>
Inhibition of human IAPP fibril formation does not prevent beta-cell death: evidence for distinct actions of oligomers and fibrils of human IAPP
###end article-title 105
###begin article-title 106
Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases
###end article-title 106
###begin article-title 107
Heterogeneous amyloid-formed ion channels as a common cytotoxic mechanism: implications for therapeutic strategies against amyloidosis
###end article-title 107
###begin article-title 108
###xml 55 60 <span type="species:ncbi:9606">human</span>
Membrane fragmentation by an amyloidogenic fragment of human islet amyloid polypeptide detected by solid-state NMR spectroscopy of membrane nanotubes
###end article-title 108
###begin article-title 109
###xml 102 106 102 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 25 30 <span type="species:ncbi:9606">human</span>
###xml 143 149 <span type="species:ncbi:9606">humans</span>
High expression rates of human islet amyloid polypeptide induce endoplasmic reticulum stress-mediated beta-cell apoptosis, a characteristic of humans with type 2 but not type 1 diabetes
###end article-title 109
###begin article-title 110
###xml 165 169 165 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 6 11 <span type="species:ncbi:9606">human</span>
###xml 195 210 <span type="species:ncbi:10090">transgenic mice</span>
Toxic human islet amyloid polypeptide (h-IAPP) oligomers are intracellular, and vaccination to induce anti-toxic oligomer antibodies does not prevent h-IAPP-induced beta-cell apoptosis in h-IAPP transgenic mice
###end article-title 110
###begin article-title 111
###xml 30 34 30 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 71 76 <span type="species:ncbi:9606">human</span>
Two novel immortal pancreatic beta-cell lines expressing and secreting human islet amyloid polypeptide do not spontaneously develop islet amyloid
###end article-title 111
###begin article-title 112
###xml 19 24 <span type="species:ncbi:9606">human</span>
Membrane damage by human islet amyloid polypeptide through fibril growth at the membrane
###end article-title 112
###begin article-title 113
Nucleation-dependent polymerization is an essential component of amyloid-mediated neuronal cell death
###end article-title 113
###begin article-title 114
Binding of endostatin to phosphatidylserine-containing membranes and formation of amyloid-like fibers
###end article-title 114
###begin article-title 115
Formation of amyloid fibers triggered by phosphatidylserine-containing membranes
###end article-title 115
###begin article-title 116
###xml 36 41 <span type="species:ncbi:9606">human</span>
Raft lipids as common components of human extracellular amyloid fibrils
###end article-title 116
###begin article-title 117
Molecular mapping of the recognition interface between the islet amyloid polypeptide and insulin
###end article-title 117
###begin article-title 118
###xml 11 15 11 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 43 48 <span type="species:ncbi:9606">human</span>
Effects of beta cell granule components on human islet amyloid polypeptide fibril formation
###end article-title 118
###begin article-title 119
###xml 11 15 11 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
Pancreatic beta-cell granule peptides form heteromolecular complexes which inhibit islet amyloid polypeptide fibril formation
###end article-title 119
###begin article-title 120
Lipid composition of glucose-stimulated pancreatic islets and insulin-secreting tumor cells
###end article-title 120
###begin article-title 121
###xml 77 82 <span type="species:ncbi:9606">human</span>
Synergistic action of polyanionic and non-polar cofactors in fibrillation of human islet amyloid polypeptide
###end article-title 121
###begin p 122
###xml 42 47 <span type="species:ncbi:9606">human</span>
###xml 65 70 <span type="species:ncbi:10090">mouse</span>
###xml 85 90 <span type="species:ncbi:10090">Mouse</span>
###xml 113 118 <span type="species:ncbi:9606">human</span>
Comparison of the amino acid sequences of human IAPP (hIAPP) and mouse IAPP (mIAPP). Mouse IAPP differs from the human peptide by six residues (in red). The rectangle shows the N-terminal region that is thought to be important for membrane interactions. The amino acid region suggested to be important for fibril formation is represented in the underlined.
###end p 122
###begin p 123
Typical shape of the kinetics of hIAPP fibril formation, characterized by a lag phase and a sigmoidal transition. The approximate aggregation state of IAPP is indicated at the various time points. Fibril formation was induced by adding, at time 0, a monomeric stock solution of hIAPP in DMSO to buffer containing Thioflavin T.
###end p 123
###begin p 124
###xml 793 798 793 794 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
Simplified schematic representation of the different models of hIAPP-membrane interaction in relation to membrane damage and hIAPP cytotoxicity. The red rectangles show the toxic species and the red arrows show the toxic processes according to different hypotheses. The black circle represents a phospholipid membrane (vesicle), the grey circles represent hIAPP monomers, and clusters of 4 or more circles represent hIAPP oligomers and hIAPP fibrils, respectively. Membrane damage is schematically indicated by the grey arrows. Model (1) includes two steps: (i) formation of soluble hIAPP oligomers, (ii) interaction of the toxic oligomers with the membrane leading to membrane damage. Model (2) includes three steps: (i) binding of monomeric, random coil hIAPP to the membrane and folding to alpha-helix, (ii) oligomer formation of membrane-bound hIAPP, and (iii) interaction of the toxic hIAPP oligomer with the membrane leading to membrane damage. Model (3) includes 3 steps: (i) interaction of monomeric and possibly oligomeric hIAPP to the membrane, (ii) growth of hIAPP fibrils at the membrane (red arrows) leading to a forced change in membrane morphology and concomitant membrane disruption, and (iii) detachment of mature fibrils from distorted membrane.
###end p 124

